PTC THERAPEUTICS, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

PTC THERAPEUTICS, INC. reported Cash And Cash Equivalents At Carrying Value of $984.65 million for the year ending 2025.

  • PTC THERAPEUTICS, INC. showed an increase of +26.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from PTC THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
  • XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 16 years of available data (2010 to 2025), PTC THERAPEUTICS, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 3,333.8%.
  • Historical annual values: Fiscal year 2025: $984.65 million | Fiscal year 2024: $779.71 million | Fiscal year 2023: $594.00 million | Fiscal year 2022: $279.83 million | Fiscal year 2021: $189.72 million | Fiscal year 2020: $208.81 million | Fiscal year 2019: $288.03 million | Fiscal year 2018: $169.50 million | Fiscal year 2017: $111.79 million | Fiscal year 2016: $58.32 million | Fiscal year 2015: $58.02 million | Fiscal year 2014: $49.75 million | Fiscal year 2013: $15.41 million | Fiscal year 2012: $2.73 million | Fiscal year 2011: $28.43 million | Fiscal year 2010: $28.67 million.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: